Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PDSB | PDS Biotechnology Corp | Jun 24, 2024 | 1 | $0 | 4 | Jun 25, 2024 | Director |
AMAM | Ambrx Biopharma, Inc. | Mar 7, 2024 | 4 | $0 | 4 | Mar 7, 2024 | Director |
PDSB | PDS Biotechnology Corp | Jul 14, 2023 | 1 | $0 | 4 | Jul 17, 2023 | Director |
ZVSA | ZyVersa Therapeutics, Inc. | May 24, 2023 | 1 | $0 | 4 | Jul 18, 2024 | Chief Executive Officer, Director |
AMAM | Ambrx Biopharma Inc. | May 18, 2023 | 3 | $0 | 4 | Jun 9, 2023 | Director |
AMAM | Ambrx Biopharma Inc. | May 18, 2023 | 1 | $0 | 4 | May 26, 2023 | Director |
AMAM | Ambrx Biopharma Inc. | May 18, 2023 | 0 | $0 | 3 | May 19, 2023 | Director |
ZVSA | ZyVersa Therapeutics, Inc. | Dec 12, 2022 | 14 | $0 | 4 | Dec 14, 2022 | Chief Executive Officer, Director |
ZVSA | ZyVersa Therapeutics, Inc. | Dec 12, 2022 | 0 | $0 | 3 | Dec 13, 2022 | Chief Executive Officer, Director |
PDSB | PDS Biotechnology Corp | Jun 28, 2022 | 1 | $0 | 4 | Jun 29, 2022 | Director |
PDSB | PDS Biotechnology Corp | Jun 15, 2021 | 2 | $50K | 4 | Jun 17, 2021 | Director |